Assessment, management, and incidence of neonatal jaundice in healthy neonates cared for in primary care: a prospective cohort study

Abstract

Jaundice caused by hyperbilirubinaemia is a common phenomenon during the neonatal period. Population-based studies evaluating assessment, management, and incidence of jaundice and need for phototherapy among otherwise healthy neonates are scarce. We prospectively explored these aspects in a primary care setting via assessing care as usual during the control phase of a stepped wedge cluster randomised controlled trial.We conducted a prospective cohort study embedded in the Screening and TreAtment to Reduce Severe Hyperbilirubinaemia in Infants in Primary care (STARSHIP) Trial. Healthy neonates were included in seven primary care birth centres (PCBCs) in the Netherlands between July 2018 and March 2020. Neonates were eligible for inclusion if their gestational age was ≥ 35 weeks, they were admitted in a PCBC for at least 2 days during the first week of life, and if they did not previously receive phototherapy. Outcomes were the findings of visual assessment to detect jaundice, jaundice incidence and management, and the need for phototherapy treatment in the primary care setting.860 neonates were included of whom 608 (71.9%) were visibly jaundiced at some point during admission in the PCBC, with 20 being ‘very yellow’. Of the latter, four (20%) did not receive total serum bilirubin (TSB) quantification. TSB levels were not associated with the degree of visible jaundice (p = 0.416). Thirty-one neonates (3.6%) received phototherapy and none received an exchange transfusion. Five neonates did not receive phototherapy despite having a TSB level above phototherapy threshold.Jaundice is common in otherwise healthy neonates cared for in primary care. TSB quantification was not always performed in very jaundiced neonates, and not all neonates received phototherapy when indicated. Quality improvement initiatives are required, including alternative approaches to identifying potentially severe hyperbilirubinaemia.Trial registration: NL6997 (Dutch Trial Register; Old NTR ID 7187), registered 3 May 2018.

Neonatal jaundice detection in low-resource Mexican settings: possibilities and barriers for innovation with mobile health

“…Instead, the evaluation of newborns heavily relies on HCWs' subjective assessments of the extent of 'yellowness' in the baby's skin. Similar ndings have been reported in a prospective cohort study of 860 Dutch newborns assessed in primary care birth centres (37). The research revealed that TcB or TSB measurements were not quanti ed in 44% of newborns considered 'quite yellow' and in 20% considered 'very yellow'.…”

Delivery of a post-natal neonatal jaundice education intervention improves knowledge among mothers at Jinja Regional Referral Hospital in Uganda

“…Participants were recruited while in the postpartum recovery ward to ensure that they received information on neonatal jaundice before they were discharged home as all of the women in the immediate postpartum are discharged through this ward. As neonatal jaundice commonly occurs in the first week of life [ 22 ], we delivered our intervention with in the first week post-delivery with three in four of all the mothers (73.4%) receiving the enhanced neonatal jaundice education intervention within 24 hours of giving birth. All women with live born infants including preterm and low birth weight babies were eligible for inclusion.…”

The correlation between serum total bile acid and alanine aminotransferase of pregnant women and the disorders of neonatal hyperbilirubinemia-related amino acid metabolism

“…Neonatal hyperbilirubinemia (NHB) is the most common neonatal disease, with a prevalence rate of 20-40%, which is increasing year by year [ 1 ]. NHB threatens fetal health and increases the risk of long-term disease.…”